---
title: "Maternal and Early-Life Obesity Impairs CD4+ T Cell Programming and Vaccine Responses"
id: "nature-immunology-1-maternal-and-early-life-obesity-programs-cd4-t-cell-fate-to-impair-vaccine"
canonical_url: "https://medichelpline.com/clinical-feed/nature-immunology-1-maternal-and-early-life-obesity-programs-cd4-t-cell-fate-to-impair-vaccine"
content_type: "clinical_feed_article"
specialty: "Infectious Disease"
source_name: "Nature Immunology"
source_url: "https://www.nature.com/articles/s41590-026-02700-6"
published_at: "2026-11-16T12:00:00.000Z"
evidence_level: "Journal Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Maternal and Early-Life Obesity Impairs CD4+ T Cell Programming and Vaccine Responses
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/nature-immunology-1-maternal-and-early-life-obesity-programs-cd4-t-cell-fate-to-impair-vaccine
- **Specialty:** [Infectious Disease](https://medichelpline.com/clinical-feed/infectious-disease.md)
- **Primary Source:** Nature Immunology
- **Source URL:** [Original Journal Publication](https://www.nature.com/articles/s41590-026-02700-6)
- **Published At:** 2026-11-16T12:00:00.000Z
- **Evidence Rating:** Journal Feed
## Executive GIST (TL;DR)
- Investigators used a mouse model designed to reflect the epidemiological association between **maternal obesity** and childhood obesity, exposing dams or pups to a high-fat diet during pregnancy or early postnatal life. - The study team observed that exposure during pregnancy or early postnatal life, but not exposure during adulthood, altered the epigenetic and transcriptional landscape of naive **CD4+ T cells**, shifting their developmental potential. - Data indicated impaired differentiation of naive CD4+ T cells into **T follicular helper (TFH)** cells after immunization with both mRNA-based and protein-based vaccines, with downstream defects in germinal center reactions that support antibody maturation. - Mechanistically, the authors reported epigenetic repression of the ubiquitin-editing enzyme **A20 (Tnfaip3)** as a central driver of the defective TFH differentiation and impaired humoral responses. - The study group compared murine findings with human observations: pediatric patients with haploinsufficiency of **A20** displayed a notable reduction in circulating TFH cells, linking the mechanistic axis to human immune phenotypes. - The cohort findings position a defined developmental window—gestation and early postnatal life—during which metabolic exposures reprogram adaptive immunity with lasting consequences for vaccine responsiveness. - The source did not report precise vaccine doses, sample sizes, statistical values, or long-term clinical outcomes in humans beyond the described TFH reduction in A20-haploinsufficient pediatric patients. - Authors suggest that epigenetic programming of naive CD4+ T cells underlies reduced vaccine-induced germinal center activity, pointing to molecular targets for future interventions but without detailing therapeutic strategies in this report.
## Clinical Analysis & Structured Key Points
## Your privacy, your choice We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media, as well as to allow video information to be shared for both marketing, analytics and editorial purposes. By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection. See our [privacy policy](https://www.nature.com/info/privacy) for more information on the use of your personal data. Manage preferences for further information and to change your choices. Accept all cookies Reject optional cookies [Skip to main content](https://www.nature.com/articles/s41590-026-02700-6#content) Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript. Advertisement [ ![Nature Immunology](https://media.springernature.com/full/nature-cms/uploads/product/ni/header-ce329d5b570f961b651db20c364a103a.svg) ](https://www.nature.com/ni) * [ View all journals ](https://www.nature.com/siteindex) * [ Saved research ](https://www.nature.com/saved-research) * [ Search ](javascript:;) ## Search Search articles by subject, keyword or author Show results from All journals This journal Search [ Advanced search ](https://www.nature.com/search/advanced) ### Quick links * [Explore articles by subject](https://www.nature.com/subjects) * [Find a job](https://www.nature.com/naturecareers) * [Guide to authors](https://www.nature.com/authors/index.html) * [Editorial policies](https://www.nature.com/authors/editorial_policies/) * [Log in](https://idp.nature.com/auth/personal/springernature?redirect_uri=https://www.nature.com/articles/s41590-026-02700-6) * [ Content Explore content ](javascript:;) ## Explore content * [ Research articles ](https://www.nature.com/ni/research-articles) * [ Reviews & Analysis ](https://www.nature.com/ni/reviews-and-analysis) * [ News & Comment ](https://www.nature.com/ni/news-and-comment) * [ Videos ](https://www.nature.com/ni/video) * [ Current issue ](https://www.nature.com/ni/current-issue) * [ Collections ](https://www.nature.com/ni/collections) * [Follow us on X ](https://twitter.com/NatImmunol) * [Sign up for alerts ](https://journal-alerts.springernature.com/subscribe?journal_id=41590) * [ RSS feed ](https://www.nature.com/ni.rss) * [ About the journal ](javascript:;) ## About the journal * [ Aims & Scope ](https://www.nature.com/ni/aims) * [ Journal Information ](https://www.nature.com/ni/journal-information) * [ Editors ](https://www.nature.com/ni/editors) * [ Journal Metrics ](https://www.nature.com/ni/journal-impact) * [ Research Cross-Journal Editorial Team ](https://www.nature.com/ni/research-cross-journal-editorial-team) * [ Reviews Cross-Journal Editorial Team ](https://www.nature.com/ni/reviews-cross-journal-editorial-team) * [ Our publishing models ](https://www.nature.com/ni/our-publishing-models) * [ Editorial Values Statement ](https://www.nature.com/ni/editorial-values-statement) * [ Editorial Policies ](https://www.nature.com/ni/editorial-policies) * [ Content Types ](https://www.nature.com/ni/content) * [ Web Feeds ](https://www.nature.com/ni/web-feeds) * [ Posters ](https://www.nature.com/ni/posters) * [ Contact ](https://www.nature.com/ni/contact) * [ Publish with us ](javascript:;) ## Publish with us * [ Submission Guidelines ](https://www.nature.com/ni/submission-guidelines) * [ For Reviewers ](https://www.nature.com/ni/for-reviewers) * [ Language editing services ](https://authorservices.springernature.com/go/sn/?utm_source=For+Authors&utm_medium=Website_Nature&utm_campaign=Platform+Experimentation+2022&utm_id=PE2022) * [Open access funding](https://www.nature.com/ni/open-access-funding) * [Submit manuscript ](https://mts-ni.nature.com/cgi-bin/main.plex) * [ Sign up for alerts ](https://journal-alerts.springernature.com/subscribe?journal_id=41590) * [ RSS feed ](https://www.nature.com/ni.rss) 1. [nature](https://www.nature.com/) 2. [nature immunology](https://www.nature.com/ni) 3. [articles](https://www.nature.com/ni/articles?type=article) 4. article Maternal and early life obesity programs CD4+ T cell fate to impair vaccine immunity [ Download PDF ](https://www.nature.com/articles/s41590-026-02700-6.pdf) [ Download PDF ](https://www.nature.com/articles/s41590-026-02700-6.pdf) * Article * [Open access](https://www.springernature.com/gp/open-science/about/the-fundamentals-of-open-access-and-open-research) * Published: 16 November 2026 # Maternal and early life obesity programs CD4+ T cell fate to impair vaccine immunity * [Michaël F. Michieletto](https://www.nature.com/articles/s41590-026-02700-6#auth-Micha_l_F_-Michieletto-Aff1-Aff2) [ORCID: orcid.org/0000-0003-2549-8709](https://orcid.org/0000-0003-2549-8709)[1](https://www.nature.com/articles/s41590-026-02700-6#Aff1),[2](https://www.nature.com/articles/s41590-026-02700-6#Aff2) [na1](https://www.nature.com/articles/s41590-026-02700-6#na1), * [Monica T. Jimenez](https://www.nature.com/articles/s41590-026-02700-6#auth-Monica_T_-Jimenez-Aff1-Aff2)[1](https://www.nature.com/articles/s41590-026-02700-6#Aff1),[2](https://www.nature.com/articles/s41590-026-02700-6#Aff2), * [Atishay Jay](https://www.nature.com/articles/s41590-026-02700-6#auth-Atishay-Jay-Aff2-Aff3)[2](https://www.nature.com/articles/s41590-026-02700-6#Aff2),[3](https://www.nature.com/articles/s41590-026-02700-6#Aff3), * [Michelle Y. Y. Lee](https://www.nature.com/articles/s41590-026-02700-6#auth-Michelle_Y__Y_-Lee-Aff4)[4](https://www.nature.com/articles/s41590-026-02700-6#Aff4), * [Jean-Christophe Beltra](https://www.nature.com/articles/s41590-026-02700-6#auth-Jean_Christophe-Beltra-Aff2-Aff5) [ORCID: orcid.org/0000-0002-6363-3572](https://orcid.org/0000-0002-6363-3572)[2](https://www.nature.com/articles/s41590-026-02700-6#Aff2),[5](https://www.nature.com/articles/s41590-026-02700-6#Aff5), * [Corentin Le Saos-Patrinos](https://www.nature.com/articles/s41590-026-02700-6#auth-Corentin-Saos_Patrinos-Aff2-Aff6) [ORCID: orcid.org/0009-0002-1704-5240](https://orcid.org/0009-0002-1704-5240)[2](https://www.nature.com/articles/s41590-026-02700-6#Aff2),[6](https://www.nature.com/articles/s41590-026-02700-6#Aff6), * [Samir U. Sayed](https://www.nature.com/articles/s41590-026-02700-6#auth-Samir_U_-Sayed-Aff7) [ORCID: orcid.org/0000-0003-4981-5721](https://orcid.org/0000-0003-4981-5721)[7](https://www.nature.com/articles/s41590-026-02700-6#Aff7), * [Megan L. Clark](https://www.nature.com/articles/s41590-026-02700-6#auth-Megan_L_-Clark-Aff1-Aff2) [ORCID: orcid.org/0000-0002-2631-3721](https://orcid.org/0000-0002-2631-3721)[1](https://www.nature.com/articles/s41590-026-02700-6#Aff1),[2](https://www.nature.com/articles/s41590-026-02700-6#Aff2), * [Niklas Blank](https://www.nature.com/articles/s41590-026-02700-6#auth-Niklas-Blank-Aff4)[4](https://www.nature.com/articles/s41590-026-02700-6#Aff4), * [Wallace P. Bezerra](https://www.nature.com/articles/s41590-026-02700-6#auth-Wallace_P_-Bezerra-Aff8-Aff9)[8](https://www.nature.com/articles/s41590-026-02700-6#Aff8),[9](https://www.nature.com/articles/s41590-026-02700-6#Aff9), * [Clemence Queriault](https://www.nature.com/articles/s41590-026-02700-6#auth-Clemence-Queriault-Aff10)[10](https://www.nature.com/articles/s41590-026-02700-6#Aff10), * [Ceire Hay](https://www.nature.com/articles/s41590-026-02700-6#auth-Ceire-Hay-Aff2-Aff7)[2](https://www.nature.com/articles/s41590-026-02700-6#Aff2),[7](https://www.nature.com/articles/s41590-026-02700-6#Aff7), * [Diego A. Espinoza](https://www.nature.com/articles/s41590-026-02700-6#auth-Diego_A_-Espinoza-Aff2)[2](https://www.nature.com/articles/s41590-026-02700-6#Aff2), * [Isabel R. Erickson](https://www.nature.com/articles/s41590-026-02700-6#auth-Isabel_R_-Erickson-Aff1-Aff2) [ORCID: orcid.org/0000-0003-2345-7460](https://orcid.org/0000-0003-2345-7460)[1](https://www.nature.com/articles/s41590-026-02700-6#Aff1),[2](https://www.nature.com/articles/s41590-026-02700-6#Aff2), * [Ethan A. Mack](https://www.nature.com/articles/s41590-026-02700-6#auth-Ethan_A_-Mack-Aff1-Aff2) [ORCID: orcid.org/0000-0002-4529-4917](https://orcid.org/0000-0002-4529-4917)[1](https://www.nature.com/articles/s41590-026-02700-6#Aff1),[2](https://www.nature.com/articles/s41590-026-02700-6#Aff2), * [Leonel Joannas](https://www.nature.com/articles/s41590-026-02700-6#auth-Leonel-Joannas-Aff1-Aff2)[1](https://www.nature.com/articles/s41590-026-02700-6#Aff1),[2](https://www.nature.com/articles/s41590-026-02700-6#Aff2), * [Enrique Olguín-Martínez](https://www.nature.com/articles/s41590-026-02700-6#auth-Enrique-Olgu_n_Mart_nez-Aff1-Aff2) [ORCID: orcid.org/0009-0000-4301-833X](https://orcid.org/0009-0000-4301-833X)[1](https://www.nature.com/articles/s41590-026-02700-6#Aff1),[2](https://www.nature.com/articles/s41590-026-02700-6#Aff2), * [Hiromi Muramatsu](https://www.nature.com/articles/s41590-026-02700-6#auth-Hiromi-Muramatsu-Aff6) [ORCID: orcid.org/0000-0003-1544-1493](https://orcid.org/0000-0003-1544-1493)[6](https://www.nature.com/articles/s41590-026-02700-6#Aff6), * [Mate Z. Nagy](https://www.nature.com/articles/s41590-026-02700-6#auth-Mate_Z_-Nagy-Aff2-Aff7)[2](https://www.nature.com/articles/s41590-026-02700-6#Aff2),[7](https://www.nature.com/articles/s41590-026-02700-6#Aff7), * [Sajad Ahmad Bhat](https://www.nature.com/articles/s41590-026-02700-6#auth-Sajad_Ahmad-Bhat-Aff1-Aff2)[1](https://www.nature.com/articles/s41590-026-02700-6#Aff1),[2](https://www.nature.com/articles/s41590-026-02700-6#Aff2), * [Guido H. Falduto](https://www.nature.com/articles/s41590-026-02700-6#auth-Guido_H_-Falduto-Aff11)[11](https://www.nature.com/articles/s41590-026-02700-6#Aff11), * [Ying K. Tam](https://www.nature.com/articles/s41590-026-02700-6#auth-Ying_K_-Tam-Aff12) [ORCID: orcid.org/0000-0002-4083-5251](https://orcid.org/0000-0002-4083-5251)[12](https://www.nature.com/articles/s41590-026-02700-6#Aff12), * [Zoltan Lipinszki](https://www.nature.com/articles/s41590-026-02700-6#auth-Zoltan-Lipinszki-Aff13-Aff14) [ORCID: orcid.org/0000-0002-2067-0832](https://orcid.org/0000-0002-2067-0832)[13](https://www.nature.com/articles/s41590-026-02700-6#Aff13),[14](https://www.nature.com/articles/s41590-026-02700-6#Aff14), * [Michela Locci](https://www.nature.com/articles/s41590-026-02700-6#auth-Michela-Locci-Aff2-Aff6) [ORCID: orcid.org/0000-0001-8700-671X](https://orcid.org/0000-0001-8700-671X)[2](https://www.nature.com/articles/s41590-026-02700-6#Aff2),[6](https://www.nature.com/articles/s41590-026-02700-6#Aff6), * [Diana Castano](https://www.nature.com/articles/s41590-026-02700-6#auth-Diana-Castano-Aff2-Aff6)[2](https://www.nature.com/articles/s41590-026-02700-6#Aff2),[6](https://www.nature.com/articles/s41590-026-02700-6#Aff6), * [Christoph A. Thaiss](https://www.nature.com/articles/s41590-026-02700-6#auth-Christoph_A_-Thaiss-Aff4) [ORCID: orcid.org/0000-0001-8226-7718](https://orcid.org/0000-0001-8226-7718)[4](https://www.nature.com/articles/s41590-026-02700-6#Aff4), * [Golnaz Vahedi](https://www.nature.com/articles/s41590-026-02700-6#auth-Golnaz-Vahedi-Aff2-Aff3) [ORCID: orcid.org/0000-0002-2249-8247](https://orcid.org/0000-0002-2249-8247)[2](https://www.nature.com/articles/s41590-026-02700-6#Aff2),[3](https://www.nature.com/articles/s41590-026-02700-6#Aff3), * [Adam Williams](https://www.nature.com/articles/s41590-026-02700-6#auth-Adam-Williams-Aff8-Aff9) [ORCID: orcid.org/0000-0002-5151-4103](https://orcid.org/0000-0002-5151-4103)[8](https://www.nature.com/articles/s41590-026-02700-6#Aff8),[9](https://www.nature.com/articles/s41590-026-02700-6#Aff9), * [Norbert Pardi](https://www.nature.com/articles/s41590-026-02700-6#auth-Norbert-Pardi-Aff6) [ORCID: orcid.org/0000-0003-1008-6242](https://orcid.org/0000-0003-1008-6242)[6](https://www.nature.com/articles/s41590-026-02700-6#Aff6), * [Daniella M. Schwartz](https://www.nature.com/articles/s41590-026-02700-6#auth-Daniella_M_-Schwartz-Aff11) [ORCID: orcid.org/0000-0002-1660-8438](https://orcid.org/0000-0002-1660-8438)[11](https://www.nature.com/articles/s41590-026-02700-6#Aff11), * [Tiphanie P. Vogel](https://www.nature.com/articles/s41590-026-02700-6#auth-Tiphanie_P_-Vogel-Aff15-Aff16)[15](https://www.nature.com/articles/s41590-026-02700-6#Aff15),[16](https://www.nature.com/articles/s41590-026-02700-6#Aff16), * [Sarah E. Henrickson](https://www.nature.com/articles/s41590-026-02700-6#auth-Sarah_E_-Henrickson-Aff2-Aff6-Aff7-Aff17) [ORCID: orcid.org/0000-0001-5569-4132](https://orcid.org/0000-0001-5569-4132)[2](https://www.nature.com/articles/s41590-026-02700-6#Aff2),[6](https://www.nature.com/articles/s41590-026-02700-6#Aff6),[7](https://www.nature.com/articles/s41590-026-02700-6#Aff7),[17](https://www.nature.com/articles/s41590-026-02700-6#Aff17) [na1](https://www.nature.com/articles/s41590-026-02700-6#na1) & * … * [Jorge Henao-Mejia](https://www.nature.com/articles/s41590-026-02700-6#auth-Jorge-Henao_Mejia-Aff1-Aff2-Aff10-Aff17-Aff18) [ORCID: orcid.org/0000-0003-2044-1105](https://orcid.org/0000-0003-2044-1105)[1](https://www.nature.com/articles/s41590-026-02700-6#Aff1),[2](https://www.nature.com/articles/s41590-026-02700-6#Aff2),[10](https://www.nature.com/articles/s41590-026-02700-6#Aff10),[17](https://www.nature.com/articles/s41590-026-02700-6#Aff17),[18](https://www.nature.com/articles/s41590-026-02700-6#Aff18) [na1](https://www.nature.com/articles/s41590-026-02700-6#na1) Show authors [_Nature Immunology_](https://www.nature.com/ni) (2026) [Cite this article](https://www.nature.com/articles/s41590-026-02700-6#citeas) Save article [ View saved research ](https://www.nature.com/saved-research) ## Abstract In their first 3 years, children experience an average of 14 infections and receive vaccines against roughly 15 pathogens, yet whether maternal and early life obesity alters adaptive immune responses during this critical period remains largely undefined. Using a mouse model that mirrored the epidemiological link between maternal and childhood obesity, we found that high-fat diet exposure during pregnancy or early postnatal life, but not adulthood, reshaped the epigenetic and transcriptional landscape of naive CD4+ T cells and impaired their ability to differentiate into T follicular helper (TFH) cells and support germinal center reactions in response to mRNA-based and protein-based vaccines. Mechanistically, epigenetic repression of the ubiquitin-editing enzyme A20 (_Tnfaip3_) was a central driver of these defects. Pediatric patients with haploinsufficiency of A20 displayed a marked reduction in circulating TFH cells. Altogether, these findings establish maternal and early life obesity as determinants of adaptive immunity during a critical developmental window. ### Explore related subjects Discover the latest articles and news in related subjects. * [Epigenetics in immune cells](https://www.nature.com/subjects/epigenetics-in-immune-cells) * [Lymphocyte differentiation](https://www.nature.com/subjects/lymphocyte-differentiation) * [Microbiota Influence on Vaccine Immune Responses](https://www.nature.com/subjects/microbiota-influence-on-vaccine-immune-responses) ## Main Childhood obesity is an escalating global public health crisis affecting >40 million children under 5 years of age[1](https://www.nature.com/articles/s41590-026-02700-6#ref-CR1 "Editorial. Childhood obesity: a global health crisis. Lancet 406, 1193 \(2025\)."). Maternal overweight and obesity before and during pregnancy are also associated with increased risk of childhood obesity, a major risk factor for morbidity and mortality from respiratory viral infections, including COVID-19 and influenza[2](https://www.nature.com/articles/s41590-026-02700-6#ref-CR2 "Vitoratou, D. I., Milas, G. P., Korovessi, P., Kostaridou, S. & Koletsi, P. Obesity as a risk factor for severe influenza infection in children and adolescents: a systematic review and meta-analysis. Eur. J. Pediatr. 182, 363–374 \(2023\)."). Children experience approximately 14 infections and are recommended to receive vaccines against 15 pathogens during the first 3 years of life[3](https://www.nature.com/articles/s41590-026-02700-6#ref-CR3 "Frenkel, L. D. The global burden of vaccine-preventable infectious diseases in children less than 5 years of age:implications for COVID-19 vaccination. How can we do better? Allergy Asthma Proc. 42, 378–385 \(2021\)."). However, how maternal and childhood obesity affects early life adaptive immune responses remains largely undefined. T follicular helper (TFH) cells are a specialized subset of CD4+ T cells that orchestrate B cell immune responses by guiding the selection and maturation of germinal center (GC) B cells into high-affinity, antibody-producing cells and memory B cells, critical for sustained humoral immunity. TFH cell differentiation occurs in the T cell zone of lymph nodes (LNs) and is initiated on activation of naive CD4+ T cells by type 2 conventional dendritic cells (cDC2s). In mice, this process is driven by foreign antigen recognition through the T cell receptor (TCR), costimulatory interactions and interleukin (IL)-6[4](https://www.nature.com/articles/s41590-026-02700-6#ref-CR4 "Choi, Y. S. et al. ICOS receptor instructs T follicular helper cell versus effector cell differentiation via induction of the transcriptional repressor Bcl6. Immunity 34, 932–946 \(2011\)."),[5](https://www.nature.com/articles/s41590-026-02700-6#ref-CR5 "Fazilleau, N., McHeyzer-Williams, L. J., Rosen, H. & McHeyzer-Williams, M. G. The function of follicular helper T cells is regulated by the strength of T cell antigen receptor binding. Nat. Immunol. 10, 375–384 \(2009\)."). These signals induce BCL6, the transcriptional regulator of the TFH cell lineage, and a transcriptional program characterized by CXCR5, programmed cell death protein 1 (PD-1), inducible T cell costimulator (ICOS) and IL-21 expression[5](https://www.nature.com/articles/s41590-026-02700-6#ref-CR5 "Fazilleau, N., McHeyzer-Williams, L. J., Rosen, H. & McHeyzer-Williams, M. G. The function of follicular helper T cells is regulated by the strength of T cell antigen receptor binding. Nat. Immunol. 10, 375–384 \(2009\)."),[6](https://www.nature.com/articles/s41590-026-02700-6#ref-CR6 "Crotty, S. T follicular helper cell differentiation, function, and roles in disease. Immunity 41, 529–542 \(2014\)."),[7](https://www.nature.com/articles/s41590-026-02700-6#ref-CR7 "Johnston, R. J. et al. Bcl6 and Blimp-1 are reciprocal and antagonistic regulators of T follicular helper cell differentiation. Science 325, 1006–1010 \(2009\)."),[8](https://www.nature.com/articles/s41590-026-02700-6#ref-CR8 "Li, L. et al. BAFF modulates T follicular helper cell differentiation through the BAFFR-PI3K/AKT-mTOR signaling pathway in bullous pemphigoid. J. Dermatol. Sci. 119, 18–27 \(2025\)."),[9](https://www.nature.com/articles/s41590-026-02700-6#ref-CR9 "Linterman, M. A. et al. IL-21 acts directly on B cells to regulate Bcl-6 expression and germinal center responses. J. Exp. Med. 207, 353–363 \(2010\)."),[10](https://www.nature.com/articles/s41590-026-02700-6#ref-CR10 "Nurieva, R. I. et al. Bcl6 mediates the development of T follicular helper cells. Science 325, 1001–1005 \(2009\)."),[11](https://www.nature.com/articles/s41590-026-02700-6#ref-CR11 "Schaerli, P. et al. CXC chemokine receptor 5 expression defines follicular homing T cells with B ce
## Related Clinical Research

- [Incidence of RSV in Adults ≥50 Years in the Upper Midwest After COVID-19: Community Cohort Finding](https://medichelpline.com/clinical-feed/bmj-open-6-incidence-of-respiratory-syncytial-virus-in-adults-50-years-during-and.md)
- [Crisis in Emergency Pediatric Care: Hospital Closures Impact Access](https://medichelpline.com/clinical-feed/stat-news-0-opinion-emergency-pediatric-care-is-now-in-permanent-crisis-mode.md)
- [Influenza Vaccination Associated with Lower IMV and Death Risk in Older Hospitalized Adults — Fran](https://medichelpline.com/clinical-feed/medrxiv-3-influenza-vaccination-and-disease-severity-among-older-adults-hospitalized-with.md)
- [Washington resident dies after exposure to H5N1-infected dairy cattle](https://medichelpline.com/clinical-feed/stat-news-0-washington-state-resident-dies-from-bird-flu-following-exposure-to-infected.md)
- [Severity-stratified cis-eQTL mapping identifies candidate causal genes for critical COVID-19](https://medichelpline.com/clinical-feed/medrxiv-9-severity-stratified-longitudinal-cis-eqtl-mapping-enables-high-sensitivity.md)

## Navigation
- [← Back to Infectious Disease Feed](https://medichelpline.com/clinical-feed/infectious-disease.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.